Dean Scarborough Net Worth

The estimated Net Worth of Dean A Scarborough is at least $30.3 millió dollars as of 25 April 2019. Mr. Scarborough owns over 1,336 units of Cardinal Health stock worth over $285,529 and over the last 21 years he sold CAH stock worth over $29,670,975. In addition, he makes $312,945 as Independent Director at Cardinal Health.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Scarborough CAH stock SEC Form 4 insiders trading

Dean has made over 66 trades of the Cardinal Health stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 1,336 units of CAH stock worth $145,450 on 25 April 2019.

The largest trade he's ever made was exercising 300,000 units of Cardinal Health stock on 29 April 2015 worth over $6,192,000. On average, Dean trades about 27,292 units every 47 days since 2003. As of 25 April 2019 he still owns at least 2,519 units of Cardinal Health stock.

You can see the complete history of Mr. Scarborough stock trades at the bottom of the page.

Dean Scarborough biography

Dean A. Scarborough serves as Independent Director of the Company. Mr. Scarborough served as Chairman and Chief Executive Officer of Avery Dennison Corporation, a packaging and labeling solutions company, from 2014 to 2016. Prior to that, he served as Avery Dennison’s Chairman, President and Chief Executive Officer from 2010 to 2014 and as its President and Chief Executive Officer from 2005 to 2010. After stepping down as Chief Executive Officer, Mr. Scarborough remained Chairman of the Board through April 2019. Having joined Avery Dennison in 1983, Mr. Scarborough served in a series of leadership roles both in the United States and abroad until he was appointed Chief Operating Officer in 2000 and later Chief Executive Officer. Having served as Avery Dennison’s Chief Executive Officer for 11 years, Mr. Scarborough brings to the Board substantial experience in manufacturing and distribution operations. As a former public company chief executive officer, he has relevant experience in finance, human resources and corporate governance. He also brings a global business and manufacturing perspective, having led Avery Dennison’s Label and Packaging Materials Europe business while he was based in the Netherlands. Mr. Scarborough also brings to the Board valuable perspectives and insights from his service on the board of directors of Graphic Packaging Holding Company, including its Audit Committee, and prior service on Mattel, Inc.’s board of directors.

What is the salary of Dean Scarborough?

As the Independent Director of Cardinal Health, the total compensation of Dean Scarborough at Cardinal Health is $312,945. There are 15 executives at Cardinal Health getting paid more, with Michael Kaufmann having the highest compensation of $14,217,100.

How old is Dean Scarborough?

Dean Scarborough is 64, he's been the Independent Director of Cardinal Health since 2019. There are 6 older and 20 younger executives at Cardinal Health. The oldest executive at Cardinal Health, Inc. is John Losh, 74, who is the Independent Director.

What's Dean Scarborough's mailing address?

Dean's mailing address filed with the SEC is 7000, Cardinal Place, Dublin, Washington Township, Franklin County, Ohio, 43017, United States.

Insiders trading at Cardinal Health

Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett és Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.

What does Cardinal Health do?

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Complete history of Mr. Scarborough stock trades at Mattel, Avery Dennison, Cardinal Health és Graphic Packaging Co

Cardinal Health executives and stock owners

Cardinal Health executives and other stock owners filed with the SEC include:

• Michael Kaufmann,
  Chief Executive Officer, Director
• Victor Crawford,
  Chief Executive Officer - Pharmaceutical Segment
• Jason Hollar,
  Chief Financial Officer
• Stephen Mason,
  Chief Executive Officer - Medical Segment
• Jessica Mayer,
  Chief Legal and Compliance Officer
• Michael C. Kaufmann,
  CEO & Director
• David Evans,
  Independent Director
• Victor L. Crawford,
  Chief Exec. Officer of Pharmaceutical Segment
• Jason M. Hollar,
  Chief Financial Officer
• Stephen M. Mason,
  Chief Exec. Officer of Medical Segment
• Jessica L. Mayer,
  Chief Legal & Compliance Officer
• Gregory Kenny,
  Independent Non-Executive Chairman of the Board
• Carrie Cox,
  Independent Director
• John Losh,
  Independent Director
• Bruce Downey,
  Independent Director
• Dean Scarborough,
  Independent Director
• Patricia Hemingway Hall,
  Independent Director
• John Weiland,
  Independent Director
• Calvin Darden,
  Independent Director
• Nancy Killefer,
  Independent Director
• Akhil Johri,
  Independent Director
• Sheri Edison,
  Independent Director
• Brian Rice,
  Executive Vice President, Chief Information Officer and Customer Support Services
• Ola Snow,
  Chief Human Resource Officer
• Dr. Michele A. M. Holcomb Ph.D.,
  Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer
• Brian S. Rice,
  Chief Information Officer, Exec. VP & Global Bus. Services
• Craig Cowman,
  Exec. VP of Global Sourcing
• Kevin Moran,
  VP of Investor Relations
• Patricia M. English,
  Sr. VP & Chief Accounting Officer
• Pamela O. Kimmet,
  Chief Human Resources Officer
• Michele Holcomb,
  EVP - Strategy & Corp. Dev.
• Falk T Stephen,
  EVP, Gen. Counsel & Corp. Sec.
• David P King,
  Director
• Craig S Morford,
  Chief Compliance Officer
• Colleen F. Arnold,
  Director
• Stuart G Laws,
  SVP & Chief Accounting Officer
• Donald M Jr. Casey,
  CEO, Medical Segment
• Clayton M Jones,
  Director
• David J Anderson,
  Director
• Patricia Morrison,
  Chief Information Officer
• Meghan Fitzgerald,
  EVP, Strategy & Health Policy
• Carole S Watkins,
  EVP - Human Resources
• Jon L Giacomin,
  CEO, Medical Segment
• George S Barrett,
  Chairman and CEO
• J Michael Losh,
  Director
• Deborah Weitzman,
  CEO, PSS Segment
• Jeffrey William Henderson,
  Executive Vice President
• David W Raisbeck,
  Director
• Michael A Lynch,
  CEO, Medical Segment
• Glenn Britt,
  Director
• Jean G Spaulding,
  Director
• John F Finn,
  Director
• Richard C Notebaert,
  Director
• Mark R Blake,
  EVP -- Strategy & Corp. Dev.
• James J Md Mongan,
  Director
• Jorge M Gomez,
  Chief Financial Officer
• Michael D Ohalleran,
  Director
• Vivek Jain,
  EVP - Corp Develop. & Strategy
• George H Conrades,
  Director
• Ivan K Fong,
  EVP, CLO & Secretary
• Robert D Walter,
  Chairman and CEO
• David L Schlotterbeck,
  Chmn & CEO-Clncl Techn & Svcs
• John B Mccoy,
  Director
• Philip L Francis,
  Director
• Matthew D Walter,
  Director
• R Kerry Clark,
  President and CEO
• Daniel J Walsh,
  EVP, Chf Ethcs & Compl Offcr
• Mark W Parrish,
  EVP; Group Pres.-Pharm. Distr.
• John F Havens,
  Director
• David Bing,
  Director
• Gary S Jensen,
  SVP - Corporate Controller
• Robert L Gerbig,
  Director
• Ronald K Labrum,
  CEO-Healthcare Supply Chn Svc
• Brendan A Ford,
  EVP - Corp. Development
• Anthony J Rucci,
  EVP & Chief Admin. Officer
• Joseph C Papa,
  Chmn & CEO, Pharm Techn & Svcs
• Stephen S Thomas,
  EVP-Group Pres.-AIS
• Gary D Dolch,
  EVP - Quality & Reg. Affairs
• George L Fotiades,
  President & COO
• Eric Slusser,
  SVP-Finance, CAO & Cntrllr
• Paul S Williams,
  EVP, CLO & Secretary
• Jody R Davids,
  EVP & CIO
• Richard J Miller,
  EVP & CFO
• Aaron E Alt,
  Chief Financial Officer
• Robert Azelby,
  Director
• Patricia M English,
  Chief Accounting Officer
• Christine Mundkur,
  Director
• Steven Barg,
  Director
• Michelle Brennan,
  Director
• Michelle D. Greene,
  Chief Information Officer
• Mary C. Scherer,
  Chief Accounting Officer